| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10914864 | Molecular Oncology | 2014 | 27 Pages |
Abstract
This work provides evidence of synergy of combinations of vorinostat, 17-DMAG and sorafenib in small cell sarcoma. In addition to doxorubicin, these combinations enhance doxorubicin cytotoxicity at therapeutically relevant concentrations.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
S.N. Dumont, D. Yang, A.G. Dumont, D. Reynoso, J-Y. Blay, J.C. Trent,